Early‐morning OFF and levodopa dose failures in patients with Parkinson's disease attending a routine clinical appointment using Time‐to‐ON Questionnaire

Abstract

Background and purpose In patients with Parkinson's disease (PD) with motor fluctuations, total daily OFF time is comprised of both end‐of‐dose time and the time taken to turn ON with medication. However, little is known about the impact of delays in ON time. Methods This was a single‐visit pilot study of fluctuating patients with PD attending a routine appointment. During a single visit, adult patients with idiopathic PD who were treated with levodopa for at least 1 year completed a questionnaire evaluating the time waiting for ON and the symptoms experienced while waiting to turn ON. Patients then completed a 5‐day home time‐to‐ON diary, where they documented how long it took to turn ON following their first morning dose of levodopa in 5‐min increments. Results A total of 151 consecutive patients completed the study survey, of whom 97 (64.2%) experienced motor fluctuations. Of the patients experiencing motor fluctuations, 54 (56%) reported delays in ON time (latency >30 min) following their first morning dose of levodopa. Half (51%) reported that they had experienced delayed ON at least once in the previous week and 21% reported having delayed ON during all seven mornings of the previous week. In addition, 10% of patients reported having dose failures on four or more mornings during the previous week. The most common symptoms experienced while waiting for ON were slowness (94.8%), fatigue (87.6%), reduced dexterity (82.5%), problems in walking (66.0%) and problems with balance (59.8%). Conclusion Early‐morning OFF problems such as delays in time to ON and dose failures are common in levodopa‐treated patients with PD.

Evaluation of motor complications in Parkinson’s disease: understanding the perception gap between patients and physicians

“…In our study, patients recognized morning akinesia to a greater extent than physicians, with 58.7% of patients reporting morning akinesia compared with 48.9% of physicians (Table 2). This nding is in line with the results of an Italian survey in 151 consecutive patients, which reported that 64.2% of patients were able to recognize morning akinesia [21]. Taken together, these ndings suggest that patients easily recognize the presence of morning akinesia and are therefore more likely to discuss any concerns with their physicians [19].…”

24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations

“…The primary goal of 24-h LCIG treatment is to reduce nocturnal fluctuations in motor symptoms and NMS and improve quality of sleep. Patients may benefit from 24-h LCIG administration if they experience noteworthy wearing off of symptoms overnight, delayed morning latency (i.e., delayed time to "on" following the first morning levodopa dose) [34], insomnia, stiffness, tremor, or dystonia due to wearing off of symptoms overnight, severe night-time akinesia or bradykinesia, severe night-time pain, and/or severe night-time urinary problems. Because of the limited evidence regarding 24-h LCIG infusion, the initiation of 24-h treatment should be decided individually, after weighing the potential benefits and drawbacks.…”

Could New Generations of Sensors Reshape the Management of Parkinson’s Disease?

“…Stocchi et al reported that the majority of PD patients with motor fluctuations also suffered from delays in ON time (latency > 30 min) following their first morning dose of L-dopa. [7]. However, some patients can experience an improvement of symptoms in the morning.…”